Search Results 1041-1050 of 15359 for alt

1. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 2.5 x ULN;; Aspartate transaminase (AST) ≤ 2.5 x ULN;; Total bilirubin ≤ 1.5 x ULN;; PT ≤ 1.5 x ULN (or international ...

2. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

   NOTE: If liver metastases are present, AST and ALT ≤ 5 x ULN are acceptable. Prothrombin time (PT)/international normalized ratio (INR)/partial ...

3. A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. - Mayo Clinic

   * For participants initiating OL tolebrutinib in the LTS17043 study: Confirmed unblinding visit (RMS) or opt-in visit (PMS) alanine aminotransferase (ALT) ...

4. Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer - Mayo Clinic

   ALT and AST ≤ 5 X upper limit of normal; Amylase and lipase 1,5 X upper limit of normal; Serum creatinine ≤ 1.5 X upper limit of normal; INR < 2.0. Exclusion ...

5. A Study of Using Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy - Mayo Clinic

   ... [ALT]) < 2.5 x ULN for age; All patients and/or their parents or legal guardians must sign a written informed consent. Exclusion Criteria. Patients with the ...

6. Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 5 × institutional ULN; Creatinine =< 1.5 × institutional ULN; Non-surgical cohort only: positive ...

7. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 2 x institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) ≤ 2 x institutional ULN; Total bilirubin ...

8. A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase - Mayo Clinic

   Liver dysfunction manifested by SGTP (ALT) > 5 X Upper limit of normal (ULN) and/or Aspartate aminotransferase (AST) >5 X ULN and/or direct (conjugated) ...

9. Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study - Mayo Clinic

   Bilirubin >2x upper limit of normal, in association with AST/ALT/ALP >3x upper limit normal; Allergy to apixaban and warfarin; Subjects requiring taking ...

10. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤2.5× ULN (≤× ULN if evidence of hepatic involvement by malignant disease). Creatinine ...